TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus
The transient receptor potential vanilloid type-1 (TRPV1) channels have been implicated in the modulation of aversive responses. The endocannabinoid anandamide acts as an endogenous TRPV1 agonist, exerting opposite functions at TRPV1 and type-1 cannabinoid receptors (CB1R). Here we tested the hypoth...
Saved in:
Published in | Neuropharmacology Vol. 224; p. 109314 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
15.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The transient receptor potential vanilloid type-1 (TRPV1) channels have been implicated in the modulation of aversive responses. The endocannabinoid anandamide acts as an endogenous TRPV1 agonist, exerting opposite functions at TRPV1 and type-1 cannabinoid receptors (CB1R). Here we tested the hypothesis that hippocampal TRPV1 modulates contextual fear memory retrieval and investigated the influence of the aversive stimulus intensity as well as the role of endocannabinoid signaling. Male C57BL/6J mice were tested for contextual fear memory after low-, moderate-, or high-intensity shock protocols. The selective TRPV1 blockers SB366791 (1-10 nmol) and 6-I-NC (2 nmol) were infused via intra-dorsal hippocampus before the retrieval test session. The local levels of endocannabinoids and Arc and Zif268 mRNAs, involved in synaptic plasticity and memory, were quantified. First, both TRPV1 blockers reduced memory retrieval in animals exposed to moderate or high (but not low) intensity training protocols. In the second series of results, the magnitude of the freezing responses positively correlated with the hippocampal anandamide levels; TRPV1 and CB1R were found co-localized in this brain region; and the CB1R antagonist, AM251, prevented the effects of SB366791. Thus, endocannabinoid signaling possibly mediates the effects of TRPV1 blockers. Finally, inhibition of memory retrieval by TRPV1 blockers increased Arc and Zif268 mRNAs and impaired fear memory reinstatement. In conclusion, the modulation of fear memories by dorsal hippocampal TRPV1 channels may depend on the aversive stimulus intensity and occur via anandamide/CB1 signaling. Moreover, TRPV1 blockers promote Arc and Zif268 transcription, with subsequent attenuation of aversive memory reinstatement.
•TRPV1 blockage in the hippocampus inhibits the retrieval of contextual fear memory.•The effects of TRPV1 blockers depend on the intensity of the aversive stimulus.•Retrieval of contextual fear memory increases hippocampal anandamide levels.•The effects of TRPV1 blockers depend on local anandamide/CB1R signalling. |
---|---|
AbstractList | The transient receptor potential vanilloid type-1 (TRPV1) channels have been implicated in the modulation of aversive responses. The endocannabinoid anandamide acts as an endogenous TRPV1 agonist, exerting opposite functions at TRPV1 and type-1 cannabinoid receptors (CB
R). Here we tested the hypothesis that hippocampal TRPV1 modulates contextual fear memory retrieval and investigated the influence of the aversive stimulus intensity as well as the role of endocannabinoid signaling. Male C57BL/6J mice were tested for contextual fear memory after low-, moderate-, or high-intensity shock protocols. The selective TRPV1 blockers SB366791 (1-10 nmol) and 6-I-NC (2 nmol) were infused via intra-dorsal hippocampus before the retrieval test session. The local levels of endocannabinoids and Arc and Zif268 mRNAs, involved in synaptic plasticity and memory, were quantified. First, both TRPV1 blockers reduced memory retrieval in animals exposed to moderate or high (but not low) intensity training protocols. In the second series of results, the magnitude of the freezing responses positively correlated with the hippocampal anandamide levels; TRPV1 and CB
R were found co-localized in this brain region; and the CB
R antagonist, AM251, prevented the effects of SB366791. Thus, endocannabinoid signaling possibly mediates the effects of TRPV1 blockers. Finally, inhibition of memory retrieval by TRPV1 blockers increased Arc and Zif268 mRNAs and impaired fear memory reinstatement. In conclusion, the modulation of fear memories by dorsal hippocampal TRPV1 channels may depend on the aversive stimulus intensity and occur via anandamide/CB
signaling. Moreover, TRPV1 blockers promote Arc and Zif268 transcription, with subsequent attenuation of aversive memory reinstatement. The transient receptor potential vanilloid type-1 (TRPV1) channels have been implicated in the modulation of aversive responses. The endocannabinoid anandamide acts as an endogenous TRPV1 agonist, exerting opposite functions at TRPV1 and type-1 cannabinoid receptors (CB1R). Here we tested the hypothesis that hippocampal TRPV1 modulates contextual fear memory retrieval and investigated the influence of the aversive stimulus intensity as well as the role of endocannabinoid signaling. Male C57BL/6J mice were tested for contextual fear memory after low-, moderate-, or high-intensity shock protocols. The selective TRPV1 blockers SB366791 (1-10 nmol) and 6-I-NC (2 nmol) were infused via intra-dorsal hippocampus before the retrieval test session. The local levels of endocannabinoids and Arc and Zif268 mRNAs, involved in synaptic plasticity and memory, were quantified. First, both TRPV1 blockers reduced memory retrieval in animals exposed to moderate or high (but not low) intensity training protocols. In the second series of results, the magnitude of the freezing responses positively correlated with the hippocampal anandamide levels; TRPV1 and CB1R were found co-localized in this brain region; and the CB1R antagonist, AM251, prevented the effects of SB366791. Thus, endocannabinoid signaling possibly mediates the effects of TRPV1 blockers. Finally, inhibition of memory retrieval by TRPV1 blockers increased Arc and Zif268 mRNAs and impaired fear memory reinstatement. In conclusion, the modulation of fear memories by dorsal hippocampal TRPV1 channels may depend on the aversive stimulus intensity and occur via anandamide/CB1 signaling. Moreover, TRPV1 blockers promote Arc and Zif268 transcription, with subsequent attenuation of aversive memory reinstatement. •TRPV1 blockage in the hippocampus inhibits the retrieval of contextual fear memory.•The effects of TRPV1 blockers depend on the intensity of the aversive stimulus.•Retrieval of contextual fear memory increases hippocampal anandamide levels.•The effects of TRPV1 blockers depend on local anandamide/CB1R signalling. |
ArticleNumber | 109314 |
Author | Aguiar, Daniele C. Iglesias, Lia P. Sorgi, Carlos A. Moreira, Fabrício A. Perez, Malena M. Faccioli, Lucia H. Fernandes, Heliana B. Bertoglio, Leandro J. Wotjak, Carsten T. de Miranda, Aline S. |
Author_xml | – sequence: 1 givenname: Lia P. surname: Iglesias fullname: Iglesias, Lia P. organization: Graduate School in Neuroscience and Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil – sequence: 2 givenname: Heliana B. surname: Fernandes fullname: Fernandes, Heliana B. organization: Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil – sequence: 3 givenname: Aline S. surname: de Miranda fullname: de Miranda, Aline S. organization: Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil – sequence: 4 givenname: Malena M. surname: Perez fullname: Perez, Malena M. organization: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil – sequence: 5 givenname: Lucia H. surname: Faccioli fullname: Faccioli, Lucia H. organization: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil – sequence: 6 givenname: Carlos A. surname: Sorgi fullname: Sorgi, Carlos A. organization: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil – sequence: 7 givenname: Leandro J. surname: Bertoglio fullname: Bertoglio, Leandro J. organization: Department of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil – sequence: 8 givenname: Daniele C. surname: Aguiar fullname: Aguiar, Daniele C. organization: Graduate School in Neuroscience and Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil – sequence: 9 givenname: Carsten T. surname: Wotjak fullname: Wotjak, Carsten T. organization: Central Nervous System Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach Riß, Germany – sequence: 10 givenname: Fabrício A. surname: Moreira fullname: Moreira, Fabrício A. email: fabriciomoreira@icb.ufmg.br organization: Graduate School in Neuroscience and Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36336070$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcluFDEQhi2UiEwCr4B85NKDl17cR4jYpEhEUcLVctvVGY_aduMlYo68OR5NgCN1Kanqqyr99V-iMx88IIQp2VJC-3f7rYcSw7pT0W0ZYayWR07bF2hDxcCbgfTtGdoQwkTDRyIu0GVKe0JIK6h4iS54z3lPBrJBv-7vbr9T7IIpi8o2eBxmrIPP8DMXteAZVMQOXIgHbGAFbxKuUMrWlaUkbCvpk80HrLzBtR208l5N1gdrcLKPXi2L9Y8VxHkH2ISY6tqdXddKurWkV-h8VkuC18_5Cj18-nh__aW5-fb56_X7m0bzoc3NQLkGI4zq-CT6VtOWmb4To2BjO3ZVfceGXnVq4tOkmZ7FaMgEqgajeoKWX6G3p71rDD8KpCydTRqWRXkIJUk2cM5IS8URFSdUx5BShFmu0ToVD5ISeTRA7uU_A-TRAHkyoI6-eb5SJgfm7-Cfj1fgwwmAqvXJQpRJW_BVm42gszTB_v_Kb8t3oW0 |
CitedBy_id | crossref_primary_10_1016_j_biopha_2023_115194 crossref_primary_10_1038_s41386_023_01650_z crossref_primary_10_1111_adb_13421 crossref_primary_10_1017_neu_2023_54 crossref_primary_10_1016_j_euroneuro_2023_04_017 crossref_primary_10_3390_ijms242115829 |
Cites_doi | 10.1523/JNEUROSCI.21-06-02186.2001 10.1007/s00429-013-0529-3 10.1016/j.neuron.2012.09.020 10.1016/j.bbr.2020.112734 10.1002/hipo.22527 10.1002/hipo.22826 10.1016/j.nlm.2016.01.012 10.1038/nrn3301 10.1038/npp.2008.98 10.1038/39807 10.1016/j.tins.2011.06.007 10.3389/fnbeh.2018.00079 10.7717/peerj.6493 10.1523/JNEUROSCI.21-14-05089.2001 10.1523/JNEUROSCI.4964-05.2006 10.1177/0269881117691567 10.1038/npp.2011.207 10.1523/JNEUROSCI.3303-06.2007 10.3389/fnbeh.2020.574358 10.1016/j.nlm.2012.04.008 10.1038/nm803 10.1038/s41593-019-0456-6 10.1038/22761 10.1016/j.neuropharm.2012.03.007 10.1007/7854_2009_16 10.1038/s41386-018-0274-7 10.1038/sj.bjp.0705467 10.1016/j.euroneuro.2008.07.001 10.1097/FBP.0b013e3283095234 10.1007/s00213-013-3211-9 10.1007/s00213-009-1532-5 10.1016/j.jpain.2019.11.009 10.1007/s00213-018-5121-3 10.1016/j.biopsych.2015.06.008 10.1111/j.1476-5381.2010.01157.x 10.3390/molecules26175413 10.1016/j.psyneuen.2019.104447 10.1073/pnas.1420285111 10.1016/j.neuropharm.2006.10.013 10.1016/j.euroneuro.2015.02.001 10.1038/sj.npp.1300655 10.1016/j.neuropharm.2007.07.005 10.1016/j.neuron.2019.03.017 10.1016/j.neuropharm.2016.08.020 10.1016/j.nlm.2012.01.002 10.1111/bph.15341 10.1371/journal.pone.0072006 10.1152/physrev.00018.2015 10.1016/j.nlm.2013.12.010 10.1016/j.euroneuro.2008.11.004 10.1038/nature00839 10.1038/nrn3811 10.1038/npp.2011.115 10.1523/JNEUROSCI.4112-14.2015 10.1007/s00213-018-5111-5 10.1016/j.neuroscience.2011.08.046 10.1016/bs.apha.2017.03.007 10.1038/s41386-018-0135-4 10.1016/j.neuron.2021.05.017 10.1097/FBP.0000000000000603 10.1006/meth.2001.1262 10.1016/j.bbr.2014.08.002 10.1523/JNEUROSCI.1390-20.2020 10.1038/nrn3492 10.1016/j.neuroscience.2006.02.074 10.1016/j.molbrainres.2004.12.003 10.1016/j.neuropharm.2021.108736 |
ContentType | Journal Article |
Copyright | 2022 Copyright © 2022. Published by Elsevier Ltd. |
Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.neuropharm.2022.109314 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-7064 |
EndPage | 109314 |
ExternalDocumentID | 10_1016_j_neuropharm_2022_109314 36336070 S0028390822003732 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXLA AAXUO ABCQJ ABFRF ABIVO ABJNI ABMAC ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SES SNS SPCBC SSN SSP SSZ T5K TEORI ~G- AAQFI AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM RIG .55 .GJ 29N 3O- 41~ 53G 5VS AAQXK AAYXX ABFNM ABXDB ADIYS ADMUD AGHFR AHHHB ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HMQ HMT HVGLF HZ~ R2- SEW SPT WUQ X7M XOL ZGI ZXP 7X8 |
ID | FETCH-LOGICAL-c374t-713ced8da53b864c142d65898294950935276a5ab3bbc2cf89d0beaaaa21cbe43 |
IEDL.DBID | AIKHN |
ISSN | 0028-3908 |
IngestDate | Sat Oct 05 04:38:25 EDT 2024 Thu Sep 26 19:34:05 EDT 2024 Sat Sep 28 08:18:33 EDT 2024 Fri Feb 23 02:35:33 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Fear TRPV1 Endocannabinoids Hippocampus Anandamide |
Language | English |
License | Copyright © 2022. Published by Elsevier Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c374t-713ced8da53b864c142d65898294950935276a5ab3bbc2cf89d0beaaaa21cbe43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 36336070 |
PQID | 2733204184 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2733204184 crossref_primary_10_1016_j_neuropharm_2022_109314 pubmed_primary_36336070 elsevier_sciencedirect_doi_10_1016_j_neuropharm_2022_109314 |
PublicationCentury | 2000 |
PublicationDate | 2023-02-15 |
PublicationDateYYYYMMDD | 2023-02-15 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Neuropharmacology |
PublicationTitleAlternate | Neuropharmacology |
PublicationYear | 2023 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Castillo, Younts, Chavez, Hashimotodani (bib10) 2012; 76 Howlett, Abood (bib30) 2017; 80 Mahan, Ressler (bib41) 2012; 35 Maren, Phan, Liberzon (bib42) 2013; 14 Stern, Gazarini, Vanvossen, Zuardi, Galve-Roperh, Guimaraes, Takahashi, Bertoglio (bib63) 2015; 25 Tóth, Boczán, Kedei, Lizanecz, Bagi, Papp, Edes, Csiba, Blumberg (bib66) 2005; 135 Higginbotham, Wang, Richardson, Shiina, Tan, Presker, Rossi, Fuchs (bib27) 2021; 41 Besnard, Caboche, Laroche (bib2) 2013; 8 Mechoulam, Hanuš, Pertwee, Howlett (bib45) 2014; 15 Gallo, Katche, Morici, Medina, Weisstaub (bib21) 2018; 12 Morena, Leitl, Vecchiarelli, Gray, Campolongo, Hill (bib54) 2016; 111 Hitchcock, Lattal (bib28) 2018; 28 Fogaca, Aguiar, Moreira, Guimaraes (bib20) 2012; 63 Gross, Canteras (bib24) 2012; 13 Lee, Ledri, Tóth, Marchionni, Henstridge, Dudok, Kenesei, Barna, Szabó, Renkecz, Oberoi, Watanabe, Limoli, Horvai, Soltesz, Katona (bib37) 2015; 35 Hitora-Imamura, Miura, Teshirogi, Ikegaya, Matsuki, Nomura (bib29) 2015 Diniz, Biojone, Joca, Rantamäki, Castrén, Guimarães, Casarotto (bib17) 2019; 7 Livak, Schmittgen (bib39) 2001; 25 Aguiar, Terzian, Guimaraes, Moreira (bib1) 2009; 205 Zygmunt, Petersson, Andersson, Chuang, Sørgård, Di Marzo, Julius, Högestätt (bib72) 1999; 400 Maddox, Hartmann, Ross, Ressler (bib40) 2019; 102 Caterina, Schumacher, Tominaga, Rosen, Levine, Julius (bib11) 1997; 389 Pedraza, Sierra, Boos, Haubrich, Quillfeldt, Alvares (bib58) 2016; 26 Cohen, Stackman (bib13) 2015; 285 Moreira, Kaiser, Monory, Lutz (bib51) 2008; 54 Bienvenu, Dejean, Jercog, Aouizerate, Lemoine, Herry (bib4) 2021 Santos, Stern, Bertoglio (bib60) 2008; 19 Casarotto, Terzian, Aguiar, Zangrossi, Guimaraes, Wotjak, Moreira (bib9) 2012; 37 Micale, Cristino, Tamburella, Petrosino, Leggio, Drago, Di Marzo (bib46) 2009; 34 Mobbs, Adolphs, Fanselow, Barrett, LeDoux, Ressler, Tye (bib48) 2019; 22 Vaverková, Milton, Merlo (bib67) 2020; 14 Minatohara, Akiyoshi, Okuno (bib47) 2015; 8 Escelsior, Sterlini, Murri, Serafini, Aguglia, da Silva, Corradi, Valente, Amore (bib19) 2020; 393 Bowers, Ressler (bib6) 2015; 78 Izquierdo, Furini, Myskiw (bib33) 2016; 96 Chhatwal, Davis, Maguschak, Ressler (bib12) 2005; 30 Ross (bib59) 2003; 140 Huff, Frank, Wright-Hardesty, Sprunger, Matus-Amat, Higgins, Rudy (bib31) 2006; 26 Iglesias, Aguiar, Moreira (bib32) 2022; 33 Moreira, Aguiar, Terzian, Guimaraes, Wotjak (bib50) 2012; 204 Dos Santos Corrêa, Vaz, Grisanti, de Paiva, Tiba, Fornari (bib18) 2019; 110 Gobira, Lima, Batista, de Oliveira, Resstel, Wotjak, Aguiar, Moreira (bib23) 2017; 31 Zimmermann, Bartsch, Beer, Lomazzo, Guggenhuber, Lange, Bindila, Pape, Lutz (bib71) 2019; 44 Jacob, Marsch, Marsicano, Lutz, Wotjak (bib34) 2012; 98 Kawahara, Drew, Christie, Vaughan (bib35) 2011; 163 Paxinos, Franklin (bib57) 2019 Morena, Roozendaal, Trezza, Ratano, Peloso, Hauer, Atsak, Trabace, Cuomo, McGaugh, Schelling, Campolongo (bib56) 2014; 111 Winters, Vaughan (bib69) 2021 de Oliveira, Dos Santos, Malta, Pinho, Almeida, Sorgi, Peti, Xavier, Reis, Faccioli, Cruz, Ferreira, Galdino (bib16) 2020; 21 Scienza-Martin, Lotz, Zanona, Santana-Kragelund, Crestani, Boos, Calcagnotto, Quillfeldt (bib61) 2022 Wotjak (bib70) 2019; 236 Moreira, Wotjak (bib52) 2010; 2 Guzowski, Setlow, Wagner, McGaugh (bib25) 2001; 21 Besnard, Laroche, Caboche (bib3) 2014; 219 Morena, Campolongo (bib53) 2014; 112 Moreira, Aguiar, Guimaraes (bib49) 2007; 52 Cristino, de Petrocellis, Pryce, Baker, Guglielmotti, Di Marzo (bib14) 2006; 139 Morena, Nastase, Santori, Cravatt, Shansky, Hill (bib55) 2021; 178 Vouimba, Maroun (bib68) 2011 Hall, Thomas, Everitt (bib26) 2001; 21 Terzian, Aguiar, Guimaraes, Moreira (bib64) 2009; 19 Segev, Korem, Mizrachi Zer-Aviv, Abush, Lange, Sauber, Hillard, Akirav (bib62) 2018; 43 Cahill, Milton (bib7) 2019; 236 Marsicano, Wotjak, Azad, Bisogno, Rammes, Cascio, Hermann, Tang, Hofmann, Zieglgansberger, Di Marzo, Lutz (bib44) 2002; 418 Bitencourt, Pamplona, Takahashi (bib5) 2008; 18 Terzian, dos Reis, Guimaraes, Correa, Resstel (bib65) 2014; 231 Kathuria, Gaetani, Fegley, Valino, Duranti, Tontini, Mor, Tarzia, La Rana, Calignano, Giustino, Tattoli, Palmery, Cuomo, Piomelli (bib36) 2003; 9 Leo, Abood (bib38) 2021; 26 Genro, de Oliveira Alvares, Quillfeldt (bib22) 2012; 97 Canto-de-Souza, Mattioli (bib8) 2016; 130 Marsch, Foeller, Rammes, Bunck, Kössl, Holsboer, Zieglgänsberger, Landgraf, Lutz, Wotjak (bib43) 2007; 27 Mechoulam (10.1016/j.neuropharm.2022.109314_bib45) 2014; 15 Tóth (10.1016/j.neuropharm.2022.109314_bib66) 2005; 135 Zimmermann (10.1016/j.neuropharm.2022.109314_bib71) 2019; 44 Besnard (10.1016/j.neuropharm.2022.109314_bib2) 2013; 8 Pedraza (10.1016/j.neuropharm.2022.109314_bib58) 2016; 26 Hall (10.1016/j.neuropharm.2022.109314_bib26) 2001; 21 Bitencourt (10.1016/j.neuropharm.2022.109314_bib5) 2008; 18 Jacob (10.1016/j.neuropharm.2022.109314_bib34) 2012; 98 Moreira (10.1016/j.neuropharm.2022.109314_bib52) 2010; 2 Hitchcock (10.1016/j.neuropharm.2022.109314_bib28) 2018; 28 Maren (10.1016/j.neuropharm.2022.109314_bib42) 2013; 14 Gobira (10.1016/j.neuropharm.2022.109314_bib23) 2017; 31 Genro (10.1016/j.neuropharm.2022.109314_bib22) 2012; 97 Escelsior (10.1016/j.neuropharm.2022.109314_bib19) 2020; 393 Chhatwal (10.1016/j.neuropharm.2022.109314_bib12) 2005; 30 Maddox (10.1016/j.neuropharm.2022.109314_bib40) 2019; 102 Moreira (10.1016/j.neuropharm.2022.109314_bib51) 2008; 54 Kawahara (10.1016/j.neuropharm.2022.109314_bib35) 2011; 163 Lee (10.1016/j.neuropharm.2022.109314_bib37) 2015; 35 Gross (10.1016/j.neuropharm.2022.109314_bib24) 2012; 13 Besnard (10.1016/j.neuropharm.2022.109314_bib3) 2014; 219 Hitora-Imamura (10.1016/j.neuropharm.2022.109314_bib29) 2015 Howlett (10.1016/j.neuropharm.2022.109314_bib30) 2017; 80 Minatohara (10.1016/j.neuropharm.2022.109314_bib47) 2015; 8 Cohen (10.1016/j.neuropharm.2022.109314_bib13) 2015; 285 Castillo (10.1016/j.neuropharm.2022.109314_bib10) 2012; 76 Kathuria (10.1016/j.neuropharm.2022.109314_bib36) 2003; 9 Mahan (10.1016/j.neuropharm.2022.109314_bib41) 2012; 35 Moreira (10.1016/j.neuropharm.2022.109314_bib49) 2007; 52 Zygmunt (10.1016/j.neuropharm.2022.109314_bib72) 1999; 400 de Oliveira (10.1016/j.neuropharm.2022.109314_bib16) 2020; 21 Morena (10.1016/j.neuropharm.2022.109314_bib53) 2014; 112 Cristino (10.1016/j.neuropharm.2022.109314_bib14) 2006; 139 Fogaca (10.1016/j.neuropharm.2022.109314_bib20) 2012; 63 Morena (10.1016/j.neuropharm.2022.109314_bib55) 2021; 178 Caterina (10.1016/j.neuropharm.2022.109314_bib11) 1997; 389 Mobbs (10.1016/j.neuropharm.2022.109314_bib48) 2019; 22 Aguiar (10.1016/j.neuropharm.2022.109314_bib1) 2009; 205 Bowers (10.1016/j.neuropharm.2022.109314_bib6) 2015; 78 Micale (10.1016/j.neuropharm.2022.109314_bib46) 2009; 34 Marsch (10.1016/j.neuropharm.2022.109314_bib43) 2007; 27 Winters (10.1016/j.neuropharm.2022.109314_bib69) 2021 Gallo (10.1016/j.neuropharm.2022.109314_bib21) 2018; 12 Livak (10.1016/j.neuropharm.2022.109314_bib39) 2001; 25 Paxinos (10.1016/j.neuropharm.2022.109314_bib57) 2019 Ross (10.1016/j.neuropharm.2022.109314_bib59) 2003; 140 Scienza-Martin (10.1016/j.neuropharm.2022.109314_bib61) 2022 Higginbotham (10.1016/j.neuropharm.2022.109314_bib27) 2021; 41 Guzowski (10.1016/j.neuropharm.2022.109314_bib25) 2001; 21 Iglesias (10.1016/j.neuropharm.2022.109314_bib32) 2022; 33 Izquierdo (10.1016/j.neuropharm.2022.109314_bib33) 2016; 96 Segev (10.1016/j.neuropharm.2022.109314_bib62) 2018; 43 Cahill (10.1016/j.neuropharm.2022.109314_bib7) 2019; 236 Santos (10.1016/j.neuropharm.2022.109314_bib60) 2008; 19 Marsicano (10.1016/j.neuropharm.2022.109314_bib44) 2002; 418 Leo (10.1016/j.neuropharm.2022.109314_bib38) 2021; 26 Huff (10.1016/j.neuropharm.2022.109314_bib31) 2006; 26 Terzian (10.1016/j.neuropharm.2022.109314_bib65) 2014; 231 Casarotto (10.1016/j.neuropharm.2022.109314_bib9) 2012; 37 Dos Santos Corrêa (10.1016/j.neuropharm.2022.109314_bib18) 2019; 110 Morena (10.1016/j.neuropharm.2022.109314_bib56) 2014; 111 Canto-de-Souza (10.1016/j.neuropharm.2022.109314_bib8) 2016; 130 Bienvenu (10.1016/j.neuropharm.2022.109314_bib4) 2021 Vaverková (10.1016/j.neuropharm.2022.109314_bib67) 2020; 14 Morena (10.1016/j.neuropharm.2022.109314_bib54) 2016; 111 Stern (10.1016/j.neuropharm.2022.109314_bib63) 2015; 25 Diniz (10.1016/j.neuropharm.2022.109314_bib17) 2019; 7 Moreira (10.1016/j.neuropharm.2022.109314_bib50) 2012; 204 Vouimba (10.1016/j.neuropharm.2022.109314_bib68) 2011 Terzian (10.1016/j.neuropharm.2022.109314_bib64) 2009; 19 Wotjak (10.1016/j.neuropharm.2022.109314_bib70) 2019; 236 |
References_xml | – volume: 219 start-page: 415 year: 2014 end-page: 430 ident: bib3 article-title: Comparative dynamics of MAPK/ERK signalling components and immediate early genes in the hippocampus and amygdala following contextual fear conditioning and retrieval publication-title: Brain Struct. Funct. contributor: fullname: Caboche – volume: 33 start-page: 2 year: 2022 end-page: 14 ident: bib32 article-title: TRPV1 blockers as potential new treatments for psychiatric disorders publication-title: Behav. Pharmacol. contributor: fullname: Moreira – volume: 205 start-page: 217 year: 2009 end-page: 225 ident: bib1 article-title: Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats publication-title: Psychopharmacology contributor: fullname: Moreira – volume: 96 start-page: 695 year: 2016 end-page: 750 ident: bib33 article-title: Fear memory publication-title: Physiol. Rev. contributor: fullname: Myskiw – volume: 76 start-page: 70 year: 2012 end-page: 81 ident: bib10 article-title: Endocannabinoid signaling and synaptic function publication-title: Neuron contributor: fullname: Hashimotodani – volume: 231 start-page: 149 year: 2014 end-page: 157 ident: bib65 article-title: Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats publication-title: Psychopharmacology contributor: fullname: Resstel – year: 2021 ident: bib4 article-title: The advent of fear conditioning as an animal model of post-traumatic stress disorder: learning from the past to shape the future of PTSD research publication-title: Neuron contributor: fullname: Herry – volume: 25 start-page: 958 year: 2015 end-page: 965 ident: bib63 article-title: Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption publication-title: Eur. Neuropsychopharmacol contributor: fullname: Bertoglio – volume: 130 start-page: 44 year: 2016 end-page: 51 ident: bib8 article-title: The consolidation of inhibitory avoidance memory in mice depends on the intensity of the aversive stimulus: the involvement of the amygdala, dorsal hippocampus and medial prefrontal cortex publication-title: Neurobiol. Learn. Mem. contributor: fullname: Mattioli – volume: 12 start-page: 79 year: 2018 ident: bib21 article-title: Immediate early genes, memory and psychiatric disorders: focus on c-fos, Egr1 and Arc publication-title: Front. Behav. Neurosci. contributor: fullname: Weisstaub – volume: 31 start-page: 750 year: 2017 end-page: 756 ident: bib23 article-title: N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: role of the cannabinoid CB1 receptor in the dorsal hippocampus publication-title: J. Psychopharmacol. contributor: fullname: Moreira – volume: 22 start-page: 1205 year: 2019 end-page: 1216 ident: bib48 article-title: Viewpoints: approaches to defining and investigating fear publication-title: Nat. Neurosci. contributor: fullname: Tye – volume: 111 start-page: 18333 year: 2014 end-page: 18338 ident: bib56 article-title: Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training publication-title: Proceed. Natl. Acad. Sci. USA contributor: fullname: Campolongo – volume: 19 start-page: 188 year: 2009 end-page: 195 ident: bib64 article-title: Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray publication-title: Eur. Neuropsychopharmacol contributor: fullname: Moreira – year: 2022 ident: bib61 article-title: Memory Consolidation Depends on Endogenous Hippocampal Levels of Anandamide: CB1 and M4, but Possibly Not TRPV1 Receptors Mediate AM404 Effects contributor: fullname: Quillfeldt – volume: 139 start-page: 1405 year: 2006 end-page: 1415 ident: bib14 article-title: Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain publication-title: Neuroscience contributor: fullname: Di Marzo – volume: 111 start-page: 59 year: 2016 end-page: 69 ident: bib54 article-title: Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety publication-title: Neuropharmacology contributor: fullname: Hill – volume: 52 start-page: 958 year: 2007 end-page: 965 ident: bib49 article-title: Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray publication-title: Neuropharmacology contributor: fullname: Guimaraes – year: 2021 ident: bib69 article-title: Mechanisms of endocannabinoid control of synaptic plasticity publication-title: Neuropharmacology contributor: fullname: Vaughan – volume: 26 start-page: 362 year: 2016 end-page: 371 ident: bib58 article-title: The dynamic nature of systems consolidation: stress during learning as a switch guiding the rate of the hippocampal dependency and memory quality publication-title: Hippocampus contributor: fullname: Alvares – volume: 393 year: 2020 ident: bib19 article-title: Red-hot chili receptors: a systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction publication-title: Behav. Brain Res. contributor: fullname: Amore – volume: 80 start-page: 169 year: 2017 end-page: 206 ident: bib30 article-title: CB1 and CBw receptor Pharmacology publication-title: Adv. Pharmacol. contributor: fullname: Abood – volume: 285 start-page: 105 year: 2015 end-page: 117 ident: bib13 article-title: Assessing rodent hippocampal involvement in the novel object recognition task publication-title: A review. Behav. Brain Res. contributor: fullname: Stackman – volume: 14 start-page: 417 year: 2013 end-page: 428 ident: bib42 article-title: The contextual brain: implications for fear conditioning, extinction and psychopathology publication-title: Nat. Rev. Neurosci. contributor: fullname: Liberzon – year: 2015 ident: bib29 article-title: Prefrontal Dopamine Regulates Fear Reinstatement through the Downregulation of Extinction Circuits contributor: fullname: Nomura – volume: 44 start-page: 1377 year: 2019 end-page: 1388 ident: bib71 article-title: Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses publication-title: Neuropsychopharmacology contributor: fullname: Lutz – volume: 37 start-page: 478 year: 2012 end-page: 486 ident: bib9 article-title: Opposing roles for cannabinoid receptor type-1 (CB(1)) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats publication-title: Neuropsychopharmacology contributor: fullname: Moreira – volume: 21 start-page: 820 year: 2020 end-page: 835 ident: bib16 article-title: Investigation of the involvement of the endocannabinoid system in TENS-induced antinociception publication-title: J. Pain contributor: fullname: Galdino – volume: 8 year: 2013 ident: bib2 article-title: Recall and reconsolidation of contextual fear memory: differential control by ERK and Zif268 expression dosage publication-title: PLoS One contributor: fullname: Laroche – volume: 28 start-page: 226 year: 2018 end-page: 238 ident: bib28 article-title: Involvement of the dorsal hippocampus in expression and extinction of cocaine-induced conditioned place preference publication-title: Hippocampus contributor: fullname: Lattal – volume: 236 start-page: 33 year: 2019 end-page: 48 ident: bib70 article-title: Sound check, stage design and screen plot - how to increase the comparability of fear conditioning and fear extinction experiments publication-title: Psychopharmacology contributor: fullname: Wotjak – volume: 135 start-page: 162 year: 2005 end-page: 168 ident: bib66 article-title: Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain publication-title: Brain Res. Mol. Brain Res. contributor: fullname: Blumberg – volume: 27 start-page: 832 year: 2007 end-page: 839 ident: bib43 article-title: Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice publication-title: J. Neurosci. contributor: fullname: Wotjak – volume: 15 start-page: 757 year: 2014 end-page: 764 ident: bib45 article-title: Early phytocannabinoid chemistry to endocannabinoids and beyond publication-title: Nat. Rev. Neurosci. contributor: fullname: Howlett – volume: 2 start-page: 429 year: 2010 end-page: 450 ident: bib52 article-title: Cannabinoids and anxiety publication-title: Curr. Top. Behav. Neurosci. contributor: fullname: Wotjak – volume: 236 start-page: 111 year: 2019 end-page: 132 ident: bib7 article-title: Neurochemical and molecular mechanisms underlying the retrieval-extinction effect publication-title: Psychopharmacology contributor: fullname: Milton – volume: 98 start-page: 47 year: 2012 end-page: 55 ident: bib34 article-title: Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo publication-title: Neurobiol. Learn. Mem. contributor: fullname: Wotjak – volume: 26 start-page: 5413 year: 2021 ident: bib38 article-title: CB1 cannabinoid receptor signaling and biased signaling publication-title: Molecules contributor: fullname: Abood – volume: 25 start-page: 402 year: 2001 end-page: 408 ident: bib39 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2- ΔΔCT method publication-title: Methods contributor: fullname: Schmittgen – volume: 78 start-page: E15 year: 2015 end-page: E27 ident: bib6 article-title: An overview of translationally informed treatments for posttraumatic stress disorder: animal models of pavlovian fear conditioning to human clinical trials publication-title: Biol. Psychiatr. contributor: fullname: Ressler – volume: 400 start-page: 452 year: 1999 end-page: 457 ident: bib72 article-title: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide publication-title: Nature contributor: fullname: Högestätt – volume: 30 start-page: 516 year: 2005 end-page: 524 ident: bib12 article-title: Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear publication-title: Neuropsychopharmacology contributor: fullname: Ressler – volume: 35 start-page: 24 year: 2012 end-page: 35 ident: bib41 article-title: Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder publication-title: Trends Neurosci. contributor: fullname: Ressler – volume: 178 start-page: 983 year: 2021 end-page: 996 ident: bib55 article-title: Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats publication-title: Br. J. Pharmacol. contributor: fullname: Hill – volume: 163 start-page: 1214 year: 2011 end-page: 1222 ident: bib35 article-title: Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey publication-title: Br. J. Pharmacol. contributor: fullname: Vaughan – volume: 204 start-page: 186 year: 2012 end-page: 192 ident: bib50 article-title: Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? publication-title: Neuroscience contributor: fullname: Wotjak – volume: 19 start-page: 357 year: 2008 end-page: 360 ident: bib60 article-title: Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus publication-title: Behav. Pharmacol. contributor: fullname: Bertoglio – year: 2011 ident: bib68 article-title: Learning-induced changes in mPFC–BLA connections after fear conditioning, extinction, and reinstatement of fear publication-title: Neuropsychopharmacology contributor: fullname: Maroun – volume: 41 start-page: 613 year: 2021 end-page: 629 ident: bib27 article-title: CB1 receptor signaling modulates amygdalar plasticity during context-cocaine memory reconsolidation to promote subsequent cocaine seeking publication-title: J. Neurosci. contributor: fullname: Fuchs – volume: 26 start-page: 1616 year: 2006 end-page: 1623 ident: bib31 article-title: Amygdala regulation of immediate-early gene expression in the hippocampus induced by contextual fear conditioning publication-title: J. Neurosci. contributor: fullname: Rudy – year: 2019 ident: bib57 article-title: Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates contributor: fullname: Franklin – volume: 54 start-page: 141 year: 2008 end-page: 150 ident: bib51 article-title: Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors publication-title: Neuropharmacology contributor: fullname: Lutz – volume: 13 start-page: 651 year: 2012 end-page: 658 ident: bib24 article-title: The many paths to fear publication-title: Nat. Rev. Neurosci. contributor: fullname: Canteras – volume: 34 start-page: 593 year: 2009 end-page: 606 ident: bib46 article-title: Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels publication-title: Neuropsychopharmacology contributor: fullname: Di Marzo – volume: 35 start-page: 10039 year: 2015 end-page: 10057 ident: bib37 article-title: Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release publication-title: J. Neurosci. contributor: fullname: Katona – volume: 389 start-page: 816 year: 1997 end-page: 824 ident: bib11 article-title: The capsaicin receptor: a heat-activated ion channel in the pain pathway publication-title: Nature contributor: fullname: Julius – volume: 8 start-page: 78 year: 2015 ident: bib47 article-title: Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace publication-title: Front. Mol. Neurosci. contributor: fullname: Okuno – volume: 112 start-page: 30 year: 2014 end-page: 43 ident: bib53 article-title: The endocannabinoid system: an emotional buffer in the modulation of memory function publication-title: Neurobiol. Learn. Mem. contributor: fullname: Campolongo – volume: 43 start-page: 2017 year: 2018 end-page: 2027 ident: bib62 article-title: Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity publication-title: Neuropsychopharmacology contributor: fullname: Akirav – volume: 63 start-page: 202 year: 2012 end-page: 210 ident: bib20 article-title: The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior publication-title: Neuropharmacology contributor: fullname: Guimaraes – volume: 418 start-page: 530 year: 2002 end-page: 534 ident: bib44 article-title: The endogenous cannabinoid system controls extinction of aversive memories publication-title: Nature contributor: fullname: Lutz – volume: 9 start-page: 76 year: 2003 end-page: 81 ident: bib36 article-title: Modulation of anxiety through blockade of anandamide hydrolysis publication-title: Nat. Med. contributor: fullname: Piomelli – volume: 102 start-page: 60 year: 2019 end-page: 74 ident: bib40 article-title: Deconstructing the gestalt: mechanisms of fear, threat, and trauma memory encoding publication-title: Neuron contributor: fullname: Ressler – volume: 21 start-page: 5089 year: 2001 end-page: 5098 ident: bib25 article-title: Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268 publication-title: J. Neurosci. contributor: fullname: McGaugh – volume: 7 start-page: e6493 year: 2019 ident: bib17 article-title: Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors publication-title: PeerJ contributor: fullname: Casarotto – volume: 21 start-page: 2186 year: 2001 end-page: 2193 ident: bib26 article-title: Cellular imaging of zif268 expression in the hippocampus and amygdala during contextual and cued fear memory retrieval: selective activation of hippocampal CA1 neurons during the recall of contextual memories publication-title: J. Neurosci. contributor: fullname: Everitt – volume: 18 start-page: 849 year: 2008 end-page: 859 ident: bib5 article-title: Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats publication-title: Eur. Neuropsychopharmacol contributor: fullname: Takahashi – volume: 140 start-page: 790 year: 2003 end-page: 801 ident: bib59 article-title: Anandamide and vanilloid TRPV1 receptors publication-title: Br. J. Pharmacol. contributor: fullname: Ross – volume: 14 year: 2020 ident: bib67 article-title: Retrieval-dependent mechanisms affecting emotional memory persistence: reconsolidation, extinction, and the space in between publication-title: Front. Behav. Neurosci. contributor: fullname: Merlo – volume: 110 year: 2019 ident: bib18 article-title: Relationship between footshock intensity, post-training corticosterone release and contextual fear memory specificity over time publication-title: Psychoneuroendocrinology contributor: fullname: Fornari – volume: 97 start-page: 355 year: 2012 end-page: 360 ident: bib22 article-title: Role of TRPV1 in consolidation of fear memories depends on the averseness of the conditioning procedure publication-title: Neurobiol. Learn. Mem. contributor: fullname: Quillfeldt – volume: 21 start-page: 2186 year: 2001 ident: 10.1016/j.neuropharm.2022.109314_bib26 article-title: Cellular imaging of zif268 expression in the hippocampus and amygdala during contextual and cued fear memory retrieval: selective activation of hippocampal CA1 neurons during the recall of contextual memories publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.21-06-02186.2001 contributor: fullname: Hall – volume: 219 start-page: 415 year: 2014 ident: 10.1016/j.neuropharm.2022.109314_bib3 article-title: Comparative dynamics of MAPK/ERK signalling components and immediate early genes in the hippocampus and amygdala following contextual fear conditioning and retrieval publication-title: Brain Struct. Funct. doi: 10.1007/s00429-013-0529-3 contributor: fullname: Besnard – volume: 76 start-page: 70 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib10 article-title: Endocannabinoid signaling and synaptic function publication-title: Neuron doi: 10.1016/j.neuron.2012.09.020 contributor: fullname: Castillo – volume: 393 year: 2020 ident: 10.1016/j.neuropharm.2022.109314_bib19 article-title: Red-hot chili receptors: a systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2020.112734 contributor: fullname: Escelsior – volume: 26 start-page: 362 year: 2016 ident: 10.1016/j.neuropharm.2022.109314_bib58 article-title: The dynamic nature of systems consolidation: stress during learning as a switch guiding the rate of the hippocampal dependency and memory quality publication-title: Hippocampus doi: 10.1002/hipo.22527 contributor: fullname: Pedraza – volume: 28 start-page: 226 year: 2018 ident: 10.1016/j.neuropharm.2022.109314_bib28 article-title: Involvement of the dorsal hippocampus in expression and extinction of cocaine-induced conditioned place preference publication-title: Hippocampus doi: 10.1002/hipo.22826 contributor: fullname: Hitchcock – volume: 130 start-page: 44 year: 2016 ident: 10.1016/j.neuropharm.2022.109314_bib8 article-title: The consolidation of inhibitory avoidance memory in mice depends on the intensity of the aversive stimulus: the involvement of the amygdala, dorsal hippocampus and medial prefrontal cortex publication-title: Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2016.01.012 contributor: fullname: Canto-de-Souza – volume: 13 start-page: 651 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib24 article-title: The many paths to fear publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3301 contributor: fullname: Gross – volume: 34 start-page: 593 year: 2009 ident: 10.1016/j.neuropharm.2022.109314_bib46 article-title: Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.98 contributor: fullname: Micale – volume: 389 start-page: 816 year: 1997 ident: 10.1016/j.neuropharm.2022.109314_bib11 article-title: The capsaicin receptor: a heat-activated ion channel in the pain pathway publication-title: Nature doi: 10.1038/39807 contributor: fullname: Caterina – volume: 35 start-page: 24 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib41 article-title: Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder publication-title: Trends Neurosci. doi: 10.1016/j.tins.2011.06.007 contributor: fullname: Mahan – volume: 12 start-page: 79 year: 2018 ident: 10.1016/j.neuropharm.2022.109314_bib21 article-title: Immediate early genes, memory and psychiatric disorders: focus on c-fos, Egr1 and Arc publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2018.00079 contributor: fullname: Gallo – volume: 7 start-page: e6493 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib17 article-title: Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors publication-title: PeerJ doi: 10.7717/peerj.6493 contributor: fullname: Diniz – volume: 21 start-page: 5089 year: 2001 ident: 10.1016/j.neuropharm.2022.109314_bib25 article-title: Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.21-14-05089.2001 contributor: fullname: Guzowski – volume: 26 start-page: 1616 year: 2006 ident: 10.1016/j.neuropharm.2022.109314_bib31 article-title: Amygdala regulation of immediate-early gene expression in the hippocampus induced by contextual fear conditioning publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4964-05.2006 contributor: fullname: Huff – volume: 31 start-page: 750 year: 2017 ident: 10.1016/j.neuropharm.2022.109314_bib23 article-title: N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: role of the cannabinoid CB1 receptor in the dorsal hippocampus publication-title: J. Psychopharmacol. doi: 10.1177/0269881117691567 contributor: fullname: Gobira – volume: 37 start-page: 478 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib9 article-title: Opposing roles for cannabinoid receptor type-1 (CB(1)) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.207 contributor: fullname: Casarotto – volume: 27 start-page: 832 year: 2007 ident: 10.1016/j.neuropharm.2022.109314_bib43 article-title: Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3303-06.2007 contributor: fullname: Marsch – volume: 14 year: 2020 ident: 10.1016/j.neuropharm.2022.109314_bib67 article-title: Retrieval-dependent mechanisms affecting emotional memory persistence: reconsolidation, extinction, and the space in between publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2020.574358 contributor: fullname: Vaverková – volume: 98 start-page: 47 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib34 article-title: Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo publication-title: Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2012.04.008 contributor: fullname: Jacob – volume: 9 start-page: 76 year: 2003 ident: 10.1016/j.neuropharm.2022.109314_bib36 article-title: Modulation of anxiety through blockade of anandamide hydrolysis publication-title: Nat. Med. doi: 10.1038/nm803 contributor: fullname: Kathuria – volume: 22 start-page: 1205 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib48 article-title: Viewpoints: approaches to defining and investigating fear publication-title: Nat. Neurosci. doi: 10.1038/s41593-019-0456-6 contributor: fullname: Mobbs – volume: 400 start-page: 452 year: 1999 ident: 10.1016/j.neuropharm.2022.109314_bib72 article-title: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide publication-title: Nature doi: 10.1038/22761 contributor: fullname: Zygmunt – volume: 63 start-page: 202 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib20 article-title: The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.03.007 contributor: fullname: Fogaca – volume: 2 start-page: 429 year: 2010 ident: 10.1016/j.neuropharm.2022.109314_bib52 article-title: Cannabinoids and anxiety publication-title: Curr. Top. Behav. Neurosci. doi: 10.1007/7854_2009_16 contributor: fullname: Moreira – volume: 44 start-page: 1377 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib71 article-title: Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0274-7 contributor: fullname: Zimmermann – volume: 8 start-page: 78 year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib47 article-title: Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace publication-title: Front. Mol. Neurosci. contributor: fullname: Minatohara – volume: 140 start-page: 790 year: 2003 ident: 10.1016/j.neuropharm.2022.109314_bib59 article-title: Anandamide and vanilloid TRPV1 receptors publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0705467 contributor: fullname: Ross – volume: 18 start-page: 849 year: 2008 ident: 10.1016/j.neuropharm.2022.109314_bib5 article-title: Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats publication-title: Eur. Neuropsychopharmacol doi: 10.1016/j.euroneuro.2008.07.001 contributor: fullname: Bitencourt – volume: 19 start-page: 357 year: 2008 ident: 10.1016/j.neuropharm.2022.109314_bib60 article-title: Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus publication-title: Behav. Pharmacol. doi: 10.1097/FBP.0b013e3283095234 contributor: fullname: Santos – volume: 231 start-page: 149 year: 2014 ident: 10.1016/j.neuropharm.2022.109314_bib65 article-title: Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats publication-title: Psychopharmacology doi: 10.1007/s00213-013-3211-9 contributor: fullname: Terzian – volume: 205 start-page: 217 year: 2009 ident: 10.1016/j.neuropharm.2022.109314_bib1 article-title: Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats publication-title: Psychopharmacology doi: 10.1007/s00213-009-1532-5 contributor: fullname: Aguiar – volume: 21 start-page: 820 year: 2020 ident: 10.1016/j.neuropharm.2022.109314_bib16 article-title: Investigation of the involvement of the endocannabinoid system in TENS-induced antinociception publication-title: J. Pain doi: 10.1016/j.jpain.2019.11.009 contributor: fullname: de Oliveira – volume: 236 start-page: 111 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib7 article-title: Neurochemical and molecular mechanisms underlying the retrieval-extinction effect publication-title: Psychopharmacology doi: 10.1007/s00213-018-5121-3 contributor: fullname: Cahill – year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib29 contributor: fullname: Hitora-Imamura – volume: 78 start-page: E15 year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib6 article-title: An overview of translationally informed treatments for posttraumatic stress disorder: animal models of pavlovian fear conditioning to human clinical trials publication-title: Biol. Psychiatr. doi: 10.1016/j.biopsych.2015.06.008 contributor: fullname: Bowers – volume: 163 start-page: 1214 year: 2011 ident: 10.1016/j.neuropharm.2022.109314_bib35 article-title: Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2010.01157.x contributor: fullname: Kawahara – volume: 26 start-page: 5413 year: 2021 ident: 10.1016/j.neuropharm.2022.109314_bib38 article-title: CB1 cannabinoid receptor signaling and biased signaling publication-title: Molecules doi: 10.3390/molecules26175413 contributor: fullname: Leo – volume: 110 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib18 article-title: Relationship between footshock intensity, post-training corticosterone release and contextual fear memory specificity over time publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2019.104447 contributor: fullname: Dos Santos Corrêa – volume: 111 start-page: 18333 year: 2014 ident: 10.1016/j.neuropharm.2022.109314_bib56 article-title: Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training publication-title: Proceed. Natl. Acad. Sci. USA doi: 10.1073/pnas.1420285111 contributor: fullname: Morena – volume: 52 start-page: 958 year: 2007 ident: 10.1016/j.neuropharm.2022.109314_bib49 article-title: Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.10.013 contributor: fullname: Moreira – volume: 25 start-page: 958 year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib63 article-title: Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption publication-title: Eur. Neuropsychopharmacol doi: 10.1016/j.euroneuro.2015.02.001 contributor: fullname: Stern – volume: 30 start-page: 516 year: 2005 ident: 10.1016/j.neuropharm.2022.109314_bib12 article-title: Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300655 contributor: fullname: Chhatwal – volume: 54 start-page: 141 year: 2008 ident: 10.1016/j.neuropharm.2022.109314_bib51 article-title: Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2007.07.005 contributor: fullname: Moreira – volume: 102 start-page: 60 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib40 article-title: Deconstructing the gestalt: mechanisms of fear, threat, and trauma memory encoding publication-title: Neuron doi: 10.1016/j.neuron.2019.03.017 contributor: fullname: Maddox – volume: 111 start-page: 59 year: 2016 ident: 10.1016/j.neuropharm.2022.109314_bib54 article-title: Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2016.08.020 contributor: fullname: Morena – volume: 97 start-page: 355 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib22 article-title: Role of TRPV1 in consolidation of fear memories depends on the averseness of the conditioning procedure publication-title: Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2012.01.002 contributor: fullname: Genro – volume: 178 start-page: 983 year: 2021 ident: 10.1016/j.neuropharm.2022.109314_bib55 article-title: Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats publication-title: Br. J. Pharmacol. doi: 10.1111/bph.15341 contributor: fullname: Morena – volume: 8 year: 2013 ident: 10.1016/j.neuropharm.2022.109314_bib2 article-title: Recall and reconsolidation of contextual fear memory: differential control by ERK and Zif268 expression dosage publication-title: PLoS One doi: 10.1371/journal.pone.0072006 contributor: fullname: Besnard – volume: 96 start-page: 695 year: 2016 ident: 10.1016/j.neuropharm.2022.109314_bib33 article-title: Fear memory publication-title: Physiol. Rev. doi: 10.1152/physrev.00018.2015 contributor: fullname: Izquierdo – volume: 112 start-page: 30 year: 2014 ident: 10.1016/j.neuropharm.2022.109314_bib53 article-title: The endocannabinoid system: an emotional buffer in the modulation of memory function publication-title: Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2013.12.010 contributor: fullname: Morena – volume: 19 start-page: 188 year: 2009 ident: 10.1016/j.neuropharm.2022.109314_bib64 article-title: Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray publication-title: Eur. Neuropsychopharmacol doi: 10.1016/j.euroneuro.2008.11.004 contributor: fullname: Terzian – volume: 418 start-page: 530 year: 2002 ident: 10.1016/j.neuropharm.2022.109314_bib44 article-title: The endogenous cannabinoid system controls extinction of aversive memories publication-title: Nature doi: 10.1038/nature00839 contributor: fullname: Marsicano – year: 2022 ident: 10.1016/j.neuropharm.2022.109314_bib61 contributor: fullname: Scienza-Martin – volume: 15 start-page: 757 year: 2014 ident: 10.1016/j.neuropharm.2022.109314_bib45 article-title: Early phytocannabinoid chemistry to endocannabinoids and beyond publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3811 contributor: fullname: Mechoulam – year: 2011 ident: 10.1016/j.neuropharm.2022.109314_bib68 article-title: Learning-induced changes in mPFC–BLA connections after fear conditioning, extinction, and reinstatement of fear publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.115 contributor: fullname: Vouimba – volume: 35 start-page: 10039 year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib37 article-title: Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4112-14.2015 contributor: fullname: Lee – volume: 236 start-page: 33 year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib70 article-title: Sound check, stage design and screen plot - how to increase the comparability of fear conditioning and fear extinction experiments publication-title: Psychopharmacology doi: 10.1007/s00213-018-5111-5 contributor: fullname: Wotjak – volume: 204 start-page: 186 year: 2012 ident: 10.1016/j.neuropharm.2022.109314_bib50 article-title: Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.08.046 contributor: fullname: Moreira – volume: 80 start-page: 169 year: 2017 ident: 10.1016/j.neuropharm.2022.109314_bib30 article-title: CB1 and CBw receptor Pharmacology publication-title: Adv. Pharmacol. doi: 10.1016/bs.apha.2017.03.007 contributor: fullname: Howlett – volume: 43 start-page: 2017 year: 2018 ident: 10.1016/j.neuropharm.2022.109314_bib62 article-title: Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0135-4 contributor: fullname: Segev – year: 2021 ident: 10.1016/j.neuropharm.2022.109314_bib4 article-title: The advent of fear conditioning as an animal model of post-traumatic stress disorder: learning from the past to shape the future of PTSD research publication-title: Neuron doi: 10.1016/j.neuron.2021.05.017 contributor: fullname: Bienvenu – year: 2019 ident: 10.1016/j.neuropharm.2022.109314_bib57 contributor: fullname: Paxinos – volume: 33 start-page: 2 year: 2022 ident: 10.1016/j.neuropharm.2022.109314_bib32 article-title: TRPV1 blockers as potential new treatments for psychiatric disorders publication-title: Behav. Pharmacol. doi: 10.1097/FBP.0000000000000603 contributor: fullname: Iglesias – volume: 25 start-page: 402 year: 2001 ident: 10.1016/j.neuropharm.2022.109314_bib39 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2- ΔΔCT method publication-title: Methods doi: 10.1006/meth.2001.1262 contributor: fullname: Livak – volume: 285 start-page: 105 year: 2015 ident: 10.1016/j.neuropharm.2022.109314_bib13 article-title: Assessing rodent hippocampal involvement in the novel object recognition task publication-title: A review. Behav. Brain Res. doi: 10.1016/j.bbr.2014.08.002 contributor: fullname: Cohen – volume: 41 start-page: 613 year: 2021 ident: 10.1016/j.neuropharm.2022.109314_bib27 article-title: CB1 receptor signaling modulates amygdalar plasticity during context-cocaine memory reconsolidation to promote subsequent cocaine seeking publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1390-20.2020 contributor: fullname: Higginbotham – volume: 14 start-page: 417 year: 2013 ident: 10.1016/j.neuropharm.2022.109314_bib42 article-title: The contextual brain: implications for fear conditioning, extinction and psychopathology publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3492 contributor: fullname: Maren – volume: 139 start-page: 1405 year: 2006 ident: 10.1016/j.neuropharm.2022.109314_bib14 article-title: Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.02.074 contributor: fullname: Cristino – volume: 135 start-page: 162 year: 2005 ident: 10.1016/j.neuropharm.2022.109314_bib66 article-title: Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain publication-title: Brain Res. Mol. Brain Res. doi: 10.1016/j.molbrainres.2004.12.003 contributor: fullname: Tóth – year: 2021 ident: 10.1016/j.neuropharm.2022.109314_bib69 article-title: Mechanisms of endocannabinoid control of synaptic plasticity publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2021.108736 contributor: fullname: Winters |
SSID | ssj0004818 |
Score | 2.4768322 |
Snippet | The transient receptor potential vanilloid type-1 (TRPV1) channels have been implicated in the modulation of aversive responses. The endocannabinoid anandamide... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 109314 |
SubjectTerms | Anandamide Animals Endocannabinoids Endocannabinoids - pharmacology Fear Hippocampus Male Mice Mice, Inbred C57BL Receptor, Cannabinoid, CB1 TRPV Cation Channels - metabolism TRPV1 |
Title | TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus |
URI | https://dx.doi.org/10.1016/j.neuropharm.2022.109314 https://www.ncbi.nlm.nih.gov/pubmed/36336070 https://search.proquest.com/docview/2733204184 |
Volume | 224 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBbp5tJL6SvttkmYQMkpblYP2zI9hdCwTWlYyibkJiRLpi5d28Trw14K_ecZWXaWHgKF-mhLstCM5oE-fUPIhzQx1gktI-liFwkxKyJjmPP1Tah2tJC2p9j4dpXMr8XlbXy7Q87HuzAeVjnY_mDTe2s9vDkdVvO0KUt_xxddo6_Y7fFVKUc7vIvuiMkJ2T378nV-tb0eKakcyZh9hwHQE2BePW1k42miMVlkrKdXouIxL_VYFNp7o4vn5NkQRsJZmOkLsuOql-R4EXioNyew3F6rak_gGBZbhurNK_Jn-X1xQ2FV26F4F9QFeNA6WuoOhy1Q_WHlMbgbCFVyW8BGaA1W3a-uhTLg3tcb0JUF_IwOsao0Jtl1acFDQnRP9Y0NAQNMsPVdi8P-KJsGW66arn1Nri8-L8_n0VCLIcp5KtYR5rIoEWl1zI1MRE4Fsxi8ZJJlmGL501SWJjrWhhuTs7yQmZ0Zp_FhNDdO8D0yqerKvSXAJW51g3lOmmRC88I4mqC-eAhAprmZTQkd1141gXJDjVi0n2orL-XlpYK8puTTKCT1l_oo9Az_0PtolKvC3eWPTHTl6q5VGNxxNhOYBk_JmyDwhznxhPMELea7__r3e_LUV7D3QHAa75PJ-q5zBxjnrM0hefLxNz0ctPke23EBJQ |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBYhObSX0ne3bdoplJxisnrYlukphIRNkyxL2ZTchGTJxKVrm3h92GP_eUeW3SWHQCE-2pIsNNI80DffEPI1TYx1QstIuthFQkyLyBjmfH0Tqh0tpO0pNq7myexafL-Jb3bIyZgL42GVg-4POr3X1sObo2E1j5qy9Dm-aBp9xW6Pr0o56uE99AYyPJ17x-cXs_k2PVJSOZIx-w4DoCfAvHrayMbTRGOwyFhPr0TFQ1bqIS-0t0Znz8mzwY2E4zDTF2THVS_JwSLwUG8OYblNq2oP4QAWW4bqzSvyZ_lj8ZPCqrZD8S6oC_CgddTUHQ5b4PaHlcfgbiBUyW0BG6E2WHW_uxbKgHtfb0BXFvAzGsSq0hhk16UFDwnRPdU3NgR0MMHWdy0Oe1s2DbZcNV37mlyfnS5PZtFQiyHKeSrWEcayKBFpdcyNTEROBbPovGSSZRhi-dtUliY61oYbk7O8kJmdGqfxYTQ3TvA3ZLeqK_eOAJd41A3GOWmSCc0L42iC-8VDADLNzXRC6Lj2qgmUG2rEov1SW3kpLy8V5DUh30YhqXvbR6Fl-I_eX0a5Kjxd_spEV67uWoXOHWdTgWHwhLwNAv83J55wnqDGfP-of38mT2bLq0t1eT6_-ECe-mr2HhRO449kd33XuX30edbm07Cn_wISQQMZ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TRPV1+modulation+of+contextual+fear+memory+depends+on+stimulus+intensity+and+endocannabinoid+signalling+in+the+dorsal+hippocampus&rft.jtitle=Neuropharmacology&rft.au=Iglesias%2C+Lia+P&rft.au=Fernandes%2C+Heliana+B&rft.au=de+Miranda%2C+Aline+S&rft.au=Perez%2C+Malena+M&rft.date=2023-02-15&rft.eissn=1873-7064&rft.volume=224&rft.spage=109314&rft_id=info:doi/10.1016%2Fj.neuropharm.2022.109314&rft_id=info%3Apmid%2F36336070&rft.externalDocID=36336070 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-3908&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-3908&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-3908&client=summon |